NCT00084903View on ClinicalTrials.gov

Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears

NACompletedINTERVENTIONAL
Enrollment

1,070

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

July 31, 2007

Study Completion Date

February 28, 2009

Conditions
Cervical CancerPrecancerous Condition
Interventions
PROCEDURE

Colposcopic biopsy

Two small samples of cervical tissue (biopsy) removed from 2 sites as spectroscopy readings.

PROCEDURE

Light-Scattering Spectroscopy

Spectroscopy readings taken in 2 regions of cervix.

Trial Locations (2)

77030-4009

M. D. Anderson Cancer Center at University of Texas, Houston

V5Z 4E6

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00084903 - Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears | Biotech Hunter | Biotech Hunter